These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 17664462)

  • 1. A perspective on challenges and issues in biomarker development and drug and biomarker codevelopment.
    Taube SE; Clark GM; Dancey JE; McShane LM; Sigman CC; Gutman SI
    J Natl Cancer Inst; 2009 Nov; 101(21):1453-63. PubMed ID: 19855077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker phenotyping drives clinical management in axillary sentinel node: A retrospective study on women with primary breast cancer in 2002.
    Diotaiuti S; De Summa S; Altieri R; Dantona C; Tommasi S; Di Gennaro M; Rubini G; Pastena MI; Argentiero A; Zito FA; Silvestris N; Paradiso AV
    Oncol Lett; 2020 Sep; 20(3):2469-2476. PubMed ID: 32782565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale.
    Terrenato I; Arena V; Pizzamiglio S; Pennacchia I; Perracchio L; Buglioni S; Ercolani C; Sperati F; Costarelli L; Bonanno E; Baldini D; Candia S; Crescenzi A; Dal Mas A; Di Cristofano C; Gomes V; Grillo LR; Pasquini P; Pericoli MN; Ramieri MT; Di Stefano D; Ruco L; Scarpino S; Vitolo D; d'Amati G; Paradiso A; Verderio P; Mottolese M
    J Exp Clin Cancer Res; 2013 Aug; 32(1):58. PubMed ID: 23965490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue microarrays for immunohistochemical determination of oncological biomarkers.
    Verderio P; Carbone A
    Virchows Arch; 2009 Mar; 454(3):353-4. PubMed ID: 19190933
    [No Abstract]   [Full Text] [Related]  

  • 5. HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial.
    Perez EA; Suman VJ; Davidson NE; Martino S; Kaufman PA; Lingle WL; Flynn PJ; Ingle JN; Visscher D; Jenkins RB
    J Clin Oncol; 2006 Jul; 24(19):3032-8. PubMed ID: 16809727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER-2 testing in breast cancer using parallel tissue-based methods.
    Yaziji H; Goldstein LC; Barry TS; Werling R; Hwang H; Ellis GK; Gralow JR; Livingston RB; Gown AM
    JAMA; 2004 Apr; 291(16):1972-7. PubMed ID: 15113815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 testing in breast carcinoma: very low concordance rate between reference and local laboratories in Brazil.
    Wludarski SC; Lopes LF; Berto E Silva TR; Carvalho FM; Weiss LM; Bacchi CE
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):112-8. PubMed ID: 20930616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated UK Recommendations for HER2 assessment in breast cancer.
    Rakha EA; Pinder SE; Bartlett JM; Ibrahim M; Starczynski J; Carder PJ; Provenzano E; Hanby A; Hales S; Lee AH; Ellis IO;
    J Clin Pathol; 2015 Feb; 68(2):93-9. PubMed ID: 25488926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The need for a quality control of the whole process of immunohistochemistry human epidermal growth factor receptor 2/neu determination: a United Kingdom National External Quality Assessment Service/Italian Network for Quality Assessment of Tumor Biomarkers pilot experience.
    Paradiso A; Miller K; Marubini E; Pizzamiglio S; Verderio P
    J Clin Oncol; 2007 Aug; 25(22):e27-8. PubMed ID: 17664462
    [No Abstract]   [Full Text] [Related]  

  • 10. HER2+ breast cancer: review of biologic relevance and optimal use of diagnostic tools.
    Hicks DG; Kulkarni S
    Am J Clin Pathol; 2008 Feb; 129(2):263-73. PubMed ID: 18208807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HER2 testing in breast cancer].
    Yoshimura K
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():275-80. PubMed ID: 17682167
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.